{
    "eid": "2-s2.0-84905865361",
    "title": "Association of genetic variants in UGT1A6 genes and non-genetic variant with valproic acid doses and plasma concentration in Thai epileptic patients",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "Pharmacology",
            "@code": "3004"
        },
        {
            "$": "Pharmaceutical Science",
            "@code": "3003"
        }
    ],
    "keywords": [
        "Non-genetic variants",
        "Thai epileptic patients",
        "UGT1A6",
        "Valproic acid"
    ],
    "authors": [
        "Salinthip Aphichartphunkawee"
    ],
    "citedby-count": 2,
    "ref-count": 41,
    "ref-list": [
        "Valproic acid for the treatment of myeloid malignancies",
        "Valproate: A reappraisal of its pharmacodynamic properties and mechanisms of action",
        "Antiepileptic Drugs",
        "Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer",
        "The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions",
        "A mechanistic approach to antiepileptic drug interactions",
        "The relationship between the pharmacology of antiepileptic drugs and human gene variation: An overview",
        "Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects",
        "Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats",
        "Clinically important drug interactions in epilepsy: Interactions between antiepileptic drugs and other drugs",
        "Clinically relevant drug interactions with antiepileptic drugs",
        "Pharmacokinetics, drug interactions, and tolerability of valproate.",
        "Urinary excretion of valproate metabolites in children and adolescents",
        "Clinical Pharmacokinetics of Valproic Acid \u2014 1988",
        "Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10",
        "Urinary excretion of valproate and some metabolites in chronically treated patients",
        "Cloning and characterization of a canine UDP-glucuronosyltransferase",
        "Substrate specificities of two stably expressed human liver UDP- glucuronosyltransferases of the UGT1 gene family",
        "The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases",
        "Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3",
        "Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein",
        "Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs",
        "Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms",
        "The Structure and Function of the UDP-Glucuronosyltransferase Gene Family",
        "The UDP glycosyltransferase gene superfamily: Rcommended nomenclature update based on evolutionary divergence",
        "Genetic variation of human UDP-glucuronosyltransferase: Implications in disease and drug glucuronidation",
        "Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians",
        "Polymorphism of UDP-glucuronosyltransferase and drug metabolism",
        "Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: Ethnic diversity of alleles and potential clinical significance",
        "Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients",
        "Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy",
        "Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy",
        "Association of genetic variants in six candidate genes with valproic acid therapy optimization",
        "UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5\u2032-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation",
        "UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UGT1A6 polymorphisms (S7A, T181A, and R184S)",
        "Human UGT1A6 pharmacogenetics: Identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells",
        "Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: Pharmacological implications",
        "Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: Implications for patients with Gilbert's syndrome",
        "Identification of common polymorphisms in the promoter of the UGT1A9 gene: Evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver",
        "Effect of UGT1A6 genetic polymorphisms on the metabolism of sodium valproate",
        "Effect of UGTIA6 A541G genetic polymorphism on the metabolism of valproic acid in Han epileptic children from Henan"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Phramongkutklao College of Medicine",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}